Investors are looking for growth beyond the technology sector, and that’s putting dividend stocks back in favor. The idea is simple: When a stock’s growth outlook is unclear, dividends can help boost its total return and mitigate downside risk to investors’ portfolios. For example, The Coca-Cola Company NYSE: KO stock has been up about 17% in the last 12 months. When you add in the company’s dividend yield, which currently is about 2.12%, the total return for KO stock is closer to 20%. That’s something that ...

Albemarle Corporation (ALB) logged adjusted loss (barring one-time items) of 18 cents per share in the first quarter of 2025. This compares to earnings of 26 cents per share a year ago. Loss per share was narrower than the Zacks Consensus Estimate of a loss of 62 cents. Revenues fell roughly 21% year over year to $1,076.9 million in the quarter. The top line missed the Zacks Consensus Estimate of $1,171.4 million. The top line was hurt by lower prices in the Energy Storage segment, partly offset by the volu ...

DuPont de Nemours, Inc. (DD) is scheduled to come up with first-quarter 2025 results, before the opening bell on May 2.The company surpassed the Zacks Consensus Estimate in each of the trailing four quarters. In this timeframe, it delivered an earnings surprise of roughly 16.1%, on average. DD posted an earnings surprise of roughly 15.3% in the last reported quarter.DuPont is expected to have benefited from its innovation-driven investment, productivity actions and the acquisitions of the Spectrum Plastics ...

First Quarter 2025 Conference Call Tronox Holdings plc May 1, 2025 Tronox Holdings plc | tronox.com | Confidential & Proprietary | © 2025 1 Presenters John Romano John Srivisal Chief Executive Officer Senior Vice President, Chief Financial Officer Tronox Holdings plc | tronox.com | Confidential & Proprietary | © 2025 2 Safe Harbor Statement and Non-U.S. GAAP Financial Terms Cautionary Statement about Forward-Looking Statements Statements in this presentation that are not historical are forward-looking state ...

Core Insights - Ecovyst Inc. reported resilient business performance in Q1 2025, with stronger-than-expected results in the Advanced Materials & Catalysts segment, while the Ecoservices segment met expectations despite challenges [3][4] - The company anticipates increased activity in its regeneration services business due to high refinery utilization and seasonal gasoline demand starting in Q2 2025 [3][4] - Ecovyst announced an agreement to acquire Cornerstone Chemical's sulfuric acid assets for $35 million, expected to close in Q2 2025, which will enhance its Gulf Coast network and capacity [3][9] Financial Performance - Q1 2025 sales were $162.2 million, a 1.1% increase from $160.5 million in Q1 2024 [9][23] - Adjusted EBITDA for Q1 2025 was $38.9 million, down from $45.5 million in Q1 2024, reflecting a decrease in the Ecoservices segment [9][32] - The Ecoservices segment reported sales of $143.1 million, up from $141.6 million in the previous year, while Adjusted EBITDA decreased to $28.5 million from $41.5 million [4][32] Segment Analysis - Advanced Materials & Catalysts segment saw sales of $19.1 million, slightly up from $18.9 million in Q1 2024, with a significant increase in Zeolyst Joint Venture sales to $37.7 million from $23.5 million [5][32] - Adjusted EBITDA for Advanced Materials & Catalysts increased to $17.5 million from $11.1 million, driven by higher sales volume in the Zeolyst Joint Venture [5][32] Cash Flow and Balance Sheet - Cash flows from operating activities were $10.3 million in Q1 2025, down from $36.5 million in Q1 2024, primarily due to timing of dividends from the Zeolyst Joint Venture [6][9] - As of March 31, 2025, the company had cash and cash equivalents of $127.5 million and total gross debt of $868.6 million, resulting in total available liquidity of $201.1 million [6][24] 2025 Financial Outlook - The company reaffirmed its full-year Adjusted EBITDA guidance and increased sales guidance due to anticipated higher sulfur costs [7][10] - Ecoservices is expected to benefit from higher sales volumes for regeneration services and virgin sulfuric acid in the second quarter and throughout 2025 [7][10] - The company anticipates significant year-over-year sales growth in the Zeolyst Joint Venture, driven by positive momentum in hydrocracking catalyst sales [7][10]

Albemarle (ALB) reported $1.08 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 20.9%. EPS of -$0.18 for the same period compares to $0.26 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of -8.07%. The company delivered an EPS surprise of +70.97%, with the consensus EPS estimate being -$0.62.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stree ...

Core Insights - Ashland Inc. reported a mixed performance in Q2 FY2025, with sales of $479 million, a 17% decrease from $575 million in the prior year, primarily due to portfolio optimization initiatives [4][21][23] - The company revised its full-year fiscal 2025 outlook, anticipating flattish organic sales volume growth and adjusted EBITDA in the range of $400 million to $420 million [21][23] Financial Performance - Net income for Q2 was $31 million, down from $120 million in the prior year, resulting in diluted earnings per share of $0.63 compared to $2.40 [4][5] - Adjusted EBITDA was $108 million, a 14% decrease from $126 million in the prior year, primarily due to the impact of portfolio optimization and lower organic sales [5][10] - Cash flows from operating activities were $9 million, a decrease from $54 million in the prior-year quarter, with ongoing free cash flow totaling negative $6 million [7][32] Segment Performance - Life Sciences sales totaled $172 million, a 23% decrease year-over-year, primarily due to the divestiture of the Nutraceuticals segment [9][10] - Personal Care sales were $146 million, a 14% decrease, attributed to portfolio optimization and specific customer challenges [11][12] - Specialty Additives reported sales of $134 million, a 15% decrease, driven by portfolio optimization and competitive intensity in export markets [13][14] Cost Management and Optimization - The company has completed its portfolio optimization, which included the sale of Avoca and identified a $30 million cost reduction plan [3][4] - Ashland is focusing on accelerating cost savings from its $60 million manufacturing optimization plans, with early benefits evident in robust EBITDA margins above 30% in Life Sciences and Personal Care [3][4] Tariff and Trade Impact - Ashland is closely monitoring tariff policies and has estimated a tariff impact of $3 to $5 million for the second half of FY2025, increasing to $5 to $7 million annually after mitigation actions [19][20] - The company is implementing strategies to mitigate risks associated with tariffs and global trade policies while focusing on maintaining flexible operations [18][19] Market Outlook - The company anticipates a positive inflection in organic sales volumes in the second half of FY2025, led by Life Sciences, to offset declines experienced in the first half [21][24] - Ashland's strategic priorities include enhancing business mix and improving profitability in response to the evolving demand landscape [22][24]

4月30日连板股分析：高位股持续退潮 机器人板块连续两天大涨 今日共73股涨停，连板股总数10只，其中三连板及以上个股2只，上一交易日共6只连板股，连板股晋级率33.33%（不含ST股、退市股）。个股方面，全市 场超3400只个股上涨，高位股依旧表现低迷，昨日连板股中仅渝三峡A、鸿博股份2只晋级，天元股份3连跌停，昨日尝试"地天板"失败的步步高跌停，而此 前抗跌的红墙股份、永安药业、安记食品也纷纷跌停。板块方面，随着业绩披露期结束，题材炒作又有重新活跃迹象，机器人板块连续两天大涨，宁波东力 走出6天3板，全筑股份2连板，北交所倍益康30CM涨停。 | 连板数 | 晋级率 | | 2025-4-30 | | --- | --- | --- | --- | | 3 #4 | 2/2=100% | 渝三峡A(化工+业绩) | | | 1讲2 | 8/53=15% | 宁波东力 (机器人+业绩) | | | | | 东珠生态(参股AI企业) | | | | | 中欣氟材（化工+PEEK） | | | | | 汉商集团(零售+医美) | | | 其他涨停 | | 润贝航科10天5板 (大飞机+业绩) | | | | | ...

Borregaard’s operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result. Strong sales to agriculture were the main reason for the all-time high result in BioSolutions. For BioMaterials, higher sales prices were offset by lower sales volume, increased wood costs, and cos ...

Q4'24 Earnings Presentation February 27, 2025 1 Forward-Looking Statements Statements in this presentation that are not historical are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include , but are not limited to, statements regarding: our business strategy; anticipated future operating results and operating expenses, cash ...